Pfizer Inc. (N:PFE)

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for PFE within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET February 20th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Feb 14/20 Feb 13/20 Young John D Direct Ownership Phantom Stock Units SSP A - Grant, award or other under Rule 16b-3(d) 576 $36.93
Feb 14/20 Feb 13/20 Rogers Dawn Direct Ownership Phantom Stock Units SSP A - Grant, award or other under Rule 16b-3(d) 2,246 $36.93
Feb 14/20 Feb 13/20 Johnson Rady A Direct Ownership Phantom Stock Units SSP A - Grant, award or other under Rule 16b-3(d) 177 $36.93
Feb 14/20 Feb 13/20 Bourla Albert Direct Ownership Phantom Stock Units SSP A - Grant, award or other under Rule 16b-3(d) 760 $36.93
Feb 4/20 Jan 31/20 Fonseca Lidia Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -6,043 $37.24
Jan 31/20 Jan 30/20 Gottlieb Scott Direct Ownership Common Stock P - Open market or private purchase 1,000 $37.00
Jan 10/20 Jan 9/20 Young John D Direct Ownership Phantom Stock Units SSP A - Grant, award or other under Rule 16b-3(d) 36 $38.89
Jan 10/20 Jan 9/20 Rogers Dawn Direct Ownership Phantom Stock Units SSP A - Grant, award or other under Rule 16b-3(d) 217 $38.89
Jan 10/20 Jan 9/20 Johnson Rady A Direct Ownership Phantom Stock Units SSP A - Grant, award or other under Rule 16b-3(d) 18 $38.89
Jan 10/20 Jan 9/20 Bourla Albert Direct Ownership Phantom Stock Units SSP A - Grant, award or other under Rule 16b-3(d) 46 $38.89
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for PFE within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET February 20th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Feb 14/20 Feb 13/20 Young John D Direct Ownership Phantom Stock Units SSP A - Grant, award or other under Rule 16b-3(d) 576 $36.93
Feb 14/20 Feb 13/20 Rogers Dawn Direct Ownership Phantom Stock Units SSP A - Grant, award or other under Rule 16b-3(d) 2,246 $36.93
Feb 14/20 Feb 13/20 Johnson Rady A Direct Ownership Phantom Stock Units SSP A - Grant, award or other under Rule 16b-3(d) 177 $36.93
Feb 14/20 Feb 13/20 Bourla Albert Direct Ownership Phantom Stock Units SSP A - Grant, award or other under Rule 16b-3(d) 760 $36.93
Feb 4/20 Jan 31/20 Fonseca Lidia Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -6,043 $37.24
Jan 31/20 Jan 30/20 Gottlieb Scott Direct Ownership Common Stock P - Open market or private purchase 1,000 $37.00
Jan 10/20 Jan 9/20 Young John D Direct Ownership Phantom Stock Units SSP A - Grant, award or other under Rule 16b-3(d) 36 $38.89
Jan 10/20 Jan 9/20 Rogers Dawn Direct Ownership Phantom Stock Units SSP A - Grant, award or other under Rule 16b-3(d) 217 $38.89
Jan 10/20 Jan 9/20 Johnson Rady A Direct Ownership Phantom Stock Units SSP A - Grant, award or other under Rule 16b-3(d) 18 $38.89
Jan 10/20 Jan 9/20 Bourla Albert Direct Ownership Phantom Stock Units SSP A - Grant, award or other under Rule 16b-3(d) 46 $38.89
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $PFE

Competitors

Competitors with Recent Insider Filings
Horizon Therapeutics PLC (OQ:HZNP)
BridgeBio Pharma (OQ:BBIO)
Arvinas (OQ:ARVN)